Rifampin-resistant/multidrug-resistant Tuberculosis in Alberta, Canada: Epidemiology and treatment outcomes in a low-incidence setting

Treatment of rifampin-monoresistant/multidrug-resistant Tuberculosis (RR/MDR-TB) requires long treatment courses, complicated by frequent adverse events and low success rates. Incidence of RR/MDR-TB in Canada is low and treatment practices are variable due to the infrequent experience and challenges...

Descripción completa

Detalles Bibliográficos
Autores principales: Edwards, Brett D., Edwards, Jenny, Cooper, Ryan, Kunimoto, Dennis, Somayaji, Ranjani, Fisher, Dina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886202/
https://www.ncbi.nlm.nih.gov/pubmed/33592031
http://dx.doi.org/10.1371/journal.pone.0246993

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886202/
https://www.ncbi.nlm.nih.gov/pubmed/33592031
http://dx.doi.org/10.1371/journal.pone.0246993

Ejemplares similares